Literature DB >> 119302

Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system.

H Löfberg, A O Grubb.   

Abstract

Gamma-Trace was purified in large amounts from urine and used for the production of a specific rabbit antiserum. An enzyme immunoassay for quantitation of gamma-trace was developed using the pure protein as a primary standard. Its sensitivity was approximately 30 microgram/l. An enzyme amplified single radial immunodiffusion was developed as well. Its sensitivity was approximately 0.3 mg/l. These assays allowed quantitation of gamma-trace in normal human biological fluids. The following results were obtained (mean +/- SD): cerebrospinal fluid: 5.8 +/- 2.2 mg/l, plasma: 1.1 +/- 0.42 mg/l, saliva: 1.8 +/- 0.88 mg/l and urine: 0.095 +/- 0.057 mg/l. Plasma samples from patients with advanced renal failure revealed gamma-trace values up to 13 times the normal mean plasma value. The results indicate a production of gamma-trace in the central nervous system and that the protein is primarily catabolized by the kidney.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119302     DOI: 10.3109/00365517909108866

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  28 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Purification and characterization of a cystatin-type cysteine proteinase inhibitor in the human hair shaft.

Authors:  H Tsushima; A Ueki; H Mine; N Nakajima; H Sumi; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

4.  Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis.

Authors:  Shih-Han S Huang; Guido Filler; Abeer Yasin; Robert M Lindsay
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

5.  Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

Authors:  M Abrahamson; A Grubb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

7.  Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.

Authors:  A Grubb; H Löfberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

Authors:  M Lantz; H Thysell; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders.

Authors:  H Löfberg; A O Grubb; T Sveger; J E Olsson
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

10.  Cystatin C-A novel marker of glomerular filtration rate: A review.

Authors:  Purnima Dey Sarkar; G Rajeshwari; T M Shivaprakash
Journal:  Indian J Clin Biochem       Date:  2005-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.